Paul von Autenried

Board Member | CEO Advisor | Former CIO | Technology, Cybersecurity, Healthcare/Life Sciences, Manufacturing

📍 United States🔄 Updated September 2026💼 4 investments📅 6 years investing🗓 Last invested Jul 2024
VC🌍 United States
4
Total investments
1
Early stage
0
Mid stage
1
Late stage
6y
Years active

Portfolio

3 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Investor and Advisor
Mar 2023
Guava is a patient-centric app that helps people organize and take control of their health by tracking their medical records, lab tests, fitness devices, and more.
Board Member
Sep 2022
Science 37 is a clinical research site that delivers trials directly to patients homes. We accelerate research by expanding patient access to trials, leading to faster approvals and better health outcomes for all. Our solutions empower life sciences companies to reach diverse populations beyond traditional means of conducting clinical research. To learn more, visit www.science37.com or email science37@science37.com.
Board Member
Feb 2020
When you can see all aspects of your projects in one place, its easier to anticipate roadblocks and keep your complex, high-stakes initiatives on track. Quickbase helps your team mitigate risk, reduce waste, and cut down on unexpected costs by connecting your existing systems with key contributors. With automated workflows and granular permissions, the right folks will have access to the right information every time.
Experience · 5 entries
All (5)
Investments (4)
Board (3)
2024
Board Member
Jul 2024
Vbrick enables organizations to leverage the power of video to engage audiences with live video, to empower with on-demand video and to transform video content management and distribution business processes and capabilities.
2023
Investor and Advisor
Mar 2023
Guava is a patient-centric app that helps people organize and take control of their health by tracking their medical records, lab tests, fitness devices, and more.
2022
Board Member
Sep 2022
Science 37 is a clinical research site that delivers trials directly to patients homes. We accelerate research by expanding patient access to trials, leading to faster approvals and better health outcomes for all. Our solutions empower life sciences companies to reach diverse populations beyond traditional means of conducting clinical research. To learn more, visit www.science37.com or email science37@science37.com.
2020
Board Member
Feb 2020
When you can see all aspects of your projects in one place, its easier to anticipate roadblocks and keep your complex, high-stakes initiatives on track. Quickbase helps your team mitigate risk, reduce waste, and cut down on unexpected costs by connecting your existing systems with key contributors. With automated workflows and granular permissions, the right folks will have access to the right information every time.
1991
Associate Director, Manufacturing Systems
1991
Mondelēz International, Inc. (NASDAQ: MDLZ) is an American multinational confectionery, food, and beverage company based in Illinois which employs approximately 80,000 individuals around the world. Our Purpose Our purpose is to empower people to snack right. We will lead the future of snacking around the world by offering the right snack, for the right moment, made the right way. Our Brands We’re leading the future of snacking with iconic brands such as Oreo, belVita and LU biscuits; Cadbury Dairy Milk, Milka and Toblerone chocolate; Sour Patch Kids candy and Trident gum. Our People Our 80,000+ colleagues around the world are key to the success of our business. Our Values and Leadership Commitments of Love our Consumers and Brands, Grow Every Day, and Do Whats Right shapes our culture – what we believe in, stand for, and what guides our actions and decisions. Great people and great brands. That’s who we are. Our Strategies We are uniquely positioned to lead the future of snacking with strong leadership in our categories, an unparalleled portfolio of global and local brands and a solid footprint in fast-growing markets. Aimed at delivering sustainable growth, our strategic plan is centered around three strategic priorities: • Growth: accelerate consumer-centric growth • Execution: drive operational excellence • Culture: build a winning growth culture
Investment activity
2020–2024 · 4 investments
20201202212023120241
Recent (last 2 years)Earlier